Market Overview

UPDATE: Deutsche Bank Downgrades IPC The Hospitalist Company to Hold Following Q2 Results


In a report published Friday, Deutsche Bank analyst Darren Lehrich downgraded the rating on IPC The Hospitalist Company (NASDAQ: IPCM) from Buy to Hold, but reiterated the $48.00 price target.

In the report, Deutsche Bank noted, “IPCM's Q2 results were slightly below expectations due primarily to a sequential deceleration in encounter (volume) growth and flattish yoy margins. While 13.5% revenue and EBITDA growth is respectable, we believe IPCM's forward trading multiple (20.5x P/E and 11.4x EV/EBITDA) demands slightly more, and thus an earnings miss with decelerating fundamental trends seems disappointing. While we expect IPCM's EPS growth to track 14-15% over the next 24 months, we believe decelerating encounter growth (due to weaker hospital census and modestly higher physician turnover) poses some risk to the story. Moving to Hold on a more balanced risk/reward equation.”

IPC The Hospitalist Company closed on Thursday at $52.12.

Latest Ratings for IPCM

Aug 2015JefferiesDowngradesBuyHold
Aug 2015DoughertyDowngradesNeutralSell
Aug 2015William BlairDowngradesOutperformMarket Perform

View More Analyst Ratings for IPCM
View the Latest Analyst Ratings


Related Articles (IPCM)

View Comments and Join the Discussion!

Posted-In: Darren Lehrich Deutsche BankAnalyst Color Downgrades Analyst Ratings

Latest Ratings

ETNB of A SecuritiesDowngrades
HUYAB of A SecuritiesReiterates23.0
BABANomura InstinetMaintains249.0
PDDB of A SecuritiesReiterates71.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at